vs

Side-by-side financial comparison of MEDIFAST INC (MED) and NACCO INDUSTRIES INC (NC). Click either name above to swap in a different company.

MEDIFAST INC is the larger business by last-quarter revenue ($75.1M vs $62.8M, roughly 1.2× NACCO INDUSTRIES INC). On growth, NACCO INDUSTRIES INC posted the faster year-over-year revenue change (-4.3% vs -36.9%). Over the past eight quarters, NACCO INDUSTRIES INC's revenue compounded faster (9.5% CAGR vs -34.4%).

Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.

NACCO Industries, Inc. is an American publicly traded holding company, headquartered in Cleveland, Ohio. Through a portfolio of mining and natural resources businesses, the company operates under three business segments: Coal Mining, North American Mining, and Minerals Management. The Coal Mining segment operates surface coal mines under long-term contracts with power generation companies and an activated carbon producer pursuant to a service-based business model. The North American Mining se...

MED vs NC — Head-to-Head

Bigger by revenue
MED
MED
1.2× larger
MED
$75.1M
$62.8M
NC
Growing faster (revenue YoY)
NC
NC
+32.6% gap
NC
-4.3%
-36.9%
MED
Faster 2-yr revenue CAGR
NC
NC
Annualised
NC
9.5%
-34.4%
MED

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
MED
MED
NC
NC
Revenue
$75.1M
$62.8M
Net Profit
$8.8M
Gross Margin
69.4%
22.8%
Operating Margin
-10.4%
17.5%
Net Margin
14.1%
Revenue YoY
-36.9%
-4.3%
Net Profit YoY
80.0%
EPS (diluted)
$-1.64
$1.17

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MED
MED
NC
NC
Q1 26
$62.8M
Q4 25
$75.1M
$66.8M
Q3 25
$89.4M
$76.6M
Q2 25
$105.6M
$68.2M
Q1 25
$115.7M
$65.6M
Q4 24
$119.0M
$70.4M
Q3 24
$140.2M
$61.7M
Q2 24
$168.6M
$52.3M
Net Profit
MED
MED
NC
NC
Q1 26
$8.8M
Q4 25
$-3.8M
Q3 25
$-2.3M
$13.3M
Q2 25
$2.5M
$3.3M
Q1 25
$-772.0K
$4.9M
Q4 24
$7.6M
Q3 24
$1.1M
$15.6M
Q2 24
$-8.2M
$6.0M
Gross Margin
MED
MED
NC
NC
Q1 26
22.8%
Q4 25
69.4%
18.0%
Q3 25
69.5%
13.0%
Q2 25
72.6%
10.0%
Q1 25
72.8%
14.7%
Q4 24
74.1%
12.0%
Q3 24
75.4%
11.7%
Q2 24
73.2%
13.4%
Operating Margin
MED
MED
NC
NC
Q1 26
17.5%
Q4 25
-10.4%
11.3%
Q3 25
-4.6%
8.8%
Q2 25
-1.0%
-0.1%
Q1 25
-1.1%
11.7%
Q4 24
0.6%
5.5%
Q3 24
1.5%
31.9%
Q2 24
-4.7%
14.1%
Net Margin
MED
MED
NC
NC
Q1 26
14.1%
Q4 25
-5.8%
Q3 25
-2.5%
17.3%
Q2 25
2.3%
4.8%
Q1 25
-0.7%
7.5%
Q4 24
10.7%
Q3 24
0.8%
25.4%
Q2 24
-4.8%
11.4%
EPS (diluted)
MED
MED
NC
NC
Q1 26
$1.17
Q4 25
$-1.64
$-0.53
Q3 25
$-0.21
$1.78
Q2 25
$0.22
$0.44
Q1 25
$-0.07
$0.66
Q4 24
$0.08
$0.99
Q3 24
$0.10
$2.14
Q2 24
$-0.75
$0.81

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MED
MED
NC
NC
Cash + ST InvestmentsLiquidity on hand
$167.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$198.9M
Total Assets
$248.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MED
MED
NC
NC
Q1 26
Q4 25
$167.3M
$49.7M
Q3 25
$173.5M
$52.7M
Q2 25
$162.7M
$49.4M
Q1 25
$164.6M
$61.9M
Q4 24
$162.3M
$72.8M
Q3 24
$170.0M
$63.1M
Q2 24
$163.5M
$62.4M
Total Debt
MED
MED
NC
NC
Q1 26
Q4 25
$100.8M
Q3 25
Q2 25
Q1 25
Q4 24
$99.4M
Q3 24
Q2 24
$29.0M
Stockholders' Equity
MED
MED
NC
NC
Q1 26
Q4 25
$198.9M
$429.2M
Q3 25
$214.7M
$426.4M
Q2 25
$216.0M
$413.1M
Q1 25
$211.0M
$409.1M
Q4 24
$210.1M
$404.9M
Q3 24
$207.3M
$397.3M
Q2 24
$205.3M
$384.1M
Total Assets
MED
MED
NC
NC
Q1 26
Q4 25
$248.0M
$661.2M
Q3 25
$268.2M
$637.6M
Q2 25
$269.3M
$631.3M
Q1 25
$280.0M
$634.2M
Q4 24
$284.2M
$631.7M
Q3 24
$291.2M
$597.4M
Q2 24
$293.5M
$560.1M
Debt / Equity
MED
MED
NC
NC
Q1 26
Q4 25
0.23×
Q3 25
Q2 25
Q1 25
Q4 24
0.25×
Q3 24
Q2 24
0.08×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MED
MED
NC
NC
Operating Cash FlowLast quarter
$-5.3M
Free Cash FlowOCF − Capex
$-6.6M
FCF MarginFCF / Revenue
-8.8%
Capex IntensityCapex / Revenue
1.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$1.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MED
MED
NC
NC
Q1 26
Q4 25
$-5.3M
$11.4M
Q3 25
$12.1M
$42.3M
Q2 25
$-3.4M
$-7.8M
Q1 25
$3.4M
$5.0M
Q4 24
$-4.9M
$25.2M
Q3 24
$9.1M
$2.8M
Q2 24
$13.1M
$4.1M
Free Cash Flow
MED
MED
NC
NC
Q1 26
Q4 25
$-6.6M
Q3 25
$10.8M
Q2 25
$-4.8M
Q1 25
$1.9M
Q4 24
$-7.2M
Q3 24
$7.7M
Q2 24
$11.1M
FCF Margin
MED
MED
NC
NC
Q1 26
Q4 25
-8.8%
Q3 25
12.0%
Q2 25
-4.5%
Q1 25
1.6%
Q4 24
-6.1%
Q3 24
5.5%
Q2 24
6.6%
Capex Intensity
MED
MED
NC
NC
Q1 26
Q4 25
1.8%
Q3 25
1.5%
Q2 25
1.3%
Q1 25
1.3%
Q4 24
1.9%
Q3 24
1.0%
Q2 24
1.1%
Cash Conversion
MED
MED
NC
NC
Q1 26
Q4 25
Q3 25
3.19×
Q2 25
-1.36×
-2.39×
Q1 25
1.03×
Q4 24
3.33×
Q3 24
8.04×
0.18×
Q2 24
0.68×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons